Tag: alzheimer’s disease (AD)

22-NEU-3450073-CQD-Hero-650×450
December 13, 2022/Geriatrics

What’s the State of Anti-Amyloid Therapy in the Wake of Initial Clarity AD Findings?

Experts weigh in on the amyloid hypothesis and how to use lecanemab if approved

22-NEU-3383669-CQD-Hero-650×450

Big Patient Data Analyses Pinpoint Telmisartan as a Candidate Drug for Alzheimer’s in Black Adults

Findings underscore need for racial diversity in ongoing and future trials

22-NEU-3275708-CQD-Hero-650×450
October 31, 2022/Neurosciences/Brain Health

Alzheimer’s Disease in Women: How Our Understanding Continues to Evolve

Investigative highlights include hormone therapies, biomarkers and early lifestyle interventions

22-NEU-3216909-CQD-Hero-650×450
September 16, 2022/Behavioral Health

Women and Alzheimer’s Disease (Podcast)

An expert reviews risk factors and prevention strategies specific to women

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

22-NEU-2922291-CQD-Hero-Podcast-650×450-2
June 2, 2022/Geriatrics

Behavioral Symptoms in Neurodegenerative Diseases (Podcast)

Cognitive phenotypes are related to behavioral changes in Alzheimer’s and Lewy body dementia

22-NEU-2806208 dementia_650x450
March 18, 2022/Behavioral Health

Initial Cognitive Manifestation of Dementia Predicts Later Behavioral Symptoms

Risk of agitation, delusions, personality change and more is shaped by early presentation

21-NEU-2568466-CQD-Hero-2-650×450

Sildenafil Emerges as a Candidate Drug for Alzheimer’s Disease

69% relative risk reduction in large database analysis prompts plans for mechanistic and phase 2 studies

18-NEU-5689-Alzheimers-brain-650×450
August 31, 2021/Geriatrics

Large NIA Award Accelerates Efforts of Cleveland Alzheimer’s Disease Research Center

$15.4M grant to fund work on atypical Alzheimer’s, Lewy body dementia and more

21-NEU-2210808_COVID-19-neurologic-manifestations_650x450

Study Suggests Mechanistic Overlap Between Alzheimer’s and COVID-19

Links are centered on neuroinflammation and microvascular injury, network medicine study finds

20-NEU-1975345 cycling-at-home_650x450
January 19, 2021/Geriatrics

CYCLE-AD Trial: High-Intensity Exercise to Stave Off Alzheimer’s Disease

New NIH-funded study tests home-based intervention in high-risk group

BackPage 2 of 3Next
Advertisement
Ad